BJDX vs CLOV · rev $249.0K vs rev $1.37B
Bluejay Diagnostics Inc (BJDX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BJDX revenue for 2022-12-31 was $249.0K. Net income was -$9.3M. BJDX currently screens at market cap $5.0M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BJDX currently screens at market cap $5.0M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BJDX and CLOV stock pages for the full models.
Not investment advice.